Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

ClinicalTrials.gov ID: NCT01421134

Public ClinicalTrials.gov record NCT01421134. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 2:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features.

Study identification

NCT ID
NCT01421134
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
211 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2011 (Type not available)
Primary completion
Oct 2014 (Actual)
Completion
Oct 2014 (Actual)
Last update posted
Jul 15, 2016

2011 – 2014

United States locations

U.S. sites
19
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226 —
Synergy Clinical Research Center Escondido California 92025 —
Collaborative Neuroscience Network Inc. Garden Grove California 92845 —
Stanford -VA Palo Alto Health Care System Palo Alto California 94304 —
Clinical Innovations Inc. Riverside California 92506 —
Artemis Institute for Clinical Research San Diego California 92123 —
Florida Clinical Research Center, LLC Sarasota Florida 34201 —
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders Boston Massachusetts 02114 —
St. Charles Psychiatric Associates/Midwest Research Group Saint Charles Missouri 63301 —
Social Psychiatric Research Inst. (SPRI) Clinical Trials Brooklyn New York 11235 —
Village Clinical Research Inc. New York New York 10003 —
Finger Lakes Clinical Research Rochester New York 14618 —
Behavioral Medical Research of Staten Island Staten Island New York 10305 —
Psychiatry and Behavioral Sciences, Duke Durham North Carolina 27705 —
Midwest Clinical Research Center Dayton Ohio 45417 —
CRI Worldwide - Kirkbride Philadelphia Pennsylvania 19139 —
FutureSearch Trials of Dallas, LP Dallas Texas 75231 —
Dept. of Psychiatry, UT Southwestern Medical Center Dallas Texas 75390-8849 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01421134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2016 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01421134 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →